Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) FCF Margin: 2023-2025

Historic FCF Margin for Inhibrx Biosciences (INBX) over the last 2 years, with Sep 2025 value amounting to 1,063.63%.

  • Inhibrx Biosciences' FCF Margin was N/A to 1,063.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 1,609.68%, marking a year-over-year change of. This contributed to the annual value of -98,503.00% for FY2024, which is 8750844.00% down from last year.
  • Inhibrx Biosciences' FCF Margin amounted to 1,063.63% in Q3 2025, which was up 11.54% from 953.61% recorded in Q2 2025.
  • Over the past 5 years, Inhibrx Biosciences' FCF Margin peaked at 1,335.66% during Q1 2025, and registered a low of -46,062.18% during Q3 2023.
  • In the last 3 years, Inhibrx Biosciences' FCF Margin had a median value of 871.45% in 2024 and averaged -11,031.44%.
  • Per our database at Business Quant, Inhibrx Biosciences' FCF Margin plummeted by 4,004,793bps in 2024 and then surged by 54,638bps in 2025.
  • Inhibrx Biosciences' FCF Margin (Quarterly) stood at -3,688.07% in 2023, then plummeted by 4,004,793bps to -43,736.00% in 2024, then crashed by 13,896bps to 1,063.63% in 2025.
  • Its last three reported values are 1,063.63% in Q3 2025, 953.61% for Q2 2025, and 1,335.66% during Q1 2025.